Developing healthier drugs from whole-plants. MAHDL, developed to elevate HDL-C, has undergone tests in man with positive results and has an IND from the FDA. Other whole-plant therapeutics are under development for dementia.
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Mazal Plant Pharmaceuticals plus 4856 other startups.